Literature DB >> 3493062

Polyclonal polymorphic B-cell lymphoproliferative disorder with prominent pulmonary involvement in children with acquired immune deficiency syndrome.

V V Joshi, S Kauffman, J M Oleske, S Fikrig, T Denny, C Gadol, E Lee.   

Abstract

Four cases of pediatric Acquired Immune Deficiency Syndrome (AIDS) with lymphoproliferative disorder are described and other lymphoid lesions in previously reported cases of pediatric AIDS are reviewed. The lymphoproliferative disorder was characterized by polyclonal, polymorphic B-cell content without evidence of cellular atypia, necrosis or prominent mitotic activity but with predominantly extranodal systemic and prominent pulmonary involvement. Since the lesion has overlapping features it is considered to be intermediate between benign and malignant lymphoproliferations and designated as polyclonal, polymorphic B-cell lymphoproliferative disorder (PBLD) of pediatric AIDS. The PBLD is part of a spectrum of lymphoid lesions in pediatric AIDS consisting of follicular lymphoid hyperplasia of nodal and extranodal sites, pulmonary lymphoid hyperplasia/lymphoid interstitial pneumonitis complex (PLH/LIP complex) in cases previously reported by the authors, and also malignant lymphoma reported by others. It is possible that Epstein-Barr virus (EBV) by itself or in synergism with human T-lymphotropic virus-type III (HTLV-III) is related to pathogenesis of PBLD in children with AIDS.

Entities:  

Mesh:

Year:  1987        PMID: 3493062     DOI: 10.1002/1097-0142(19870415)59:8<1455::aid-cncr2820590811>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Lentivirus-induced lymphoproliferative disease. Comparative pathogenicity of phenotypically distinct ovine lentivirus strains.

Authors:  M D Lairmore; J M Poulson; T A Adducci; J C DeMartini
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

Review 2.  Pulmonary pathology in AIDS: atypical Pneumocystis carinii infection and lymphoid interstitial pneumonia.

Authors:  M J Saldana; J M Mones
Journal:  Thorax       Date:  1994       Impact factor: 9.139

3.  Exploration of the pulmonary circulation. Festschrift to Professor Donald Heath.

Authors: 
Journal:  Thorax       Date:  1994       Impact factor: 9.139

4.  Lymphocyte predominant Hodgkin's disease of nodular subtype combined with pulmonary lymphoid infiltration and hypogammaglobulinaemia.

Authors:  G Li; M L Hansmann
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Pediatric AIDS-associated lymphocytic interstitial pneumonia and pulmonary arterio-occlusive disease: role of VCAM-1/VLA-4 adhesion pathway and human herpesviruses.

Authors:  S J Brodie; C de la Rosa; J G Howe; J Crouch; W D Travis; K Diem
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

Review 6.  Epstein-Barr virus and human diseases: recent advances in diagnosis.

Authors:  M Okano; G M Thiele; J R Davis; H L Grierson; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

7.  Extranodal Marginal Zone Lymphoma of the Lung: Evolution from an Underlying Reactive Lymphoproliferative Disorder.

Authors:  Jon Nicholas Rubenstein; Colleen Beatty; Zoe Kinkade; Cara Bryan; Jeffery Paul Hogg; Laura F Gibson; Jeffrey A Vos
Journal:  J Clin Exp Pathol       Date:  2015-02-03

8.  Ovine lentivirus expression and disease. Virus replication, but not entry, is restricted to macrophages of specific tissues.

Authors:  S J Brodie; L D Pearson; M C Zink; H M Bickle; B C Anderson; K A Marcom; J C DeMartini
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

Review 9.  Pathology of AIDS in children.

Authors:  V V Joshi
Journal:  Indian J Pediatr       Date:  1994 Sep-Oct       Impact factor: 1.967

10.  Lymphoproliferative Lesions in the Setting of HIV Infection: A Five-Year Retrospective Case Series and Review.

Authors:  Etienne Mahe; Catherine Ross; Monalisa Sur
Journal:  Patholog Res Int       Date:  2011-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.